XTL Biopharmaceuticals Debt to Equity Ratio Analysis

XTL Biopharmaceuticals Ltd (XTLB)

1.44 -0.02 (-1.03%) USD | NASDAQ | Dec 20, 16:00

Debt to Equity Ratio Chart

View Debt to Equity Ratio for XTLB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Debt to Equity Ratio Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition

Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks

Start Trial

Compugen Ltd	0.00
Pluri Inc	-4.801
BioLine Rx Ltd	3.269
Can Fite Biofarma Ltd	0.00
BiomX Inc	--

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	2.928M
Total Liabilities (Quarterly)	0.223M
Shareholders Equity (Quarterly)	2.705M